Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.21.2
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Accounts payable:    
Clinical and regulatory expenses $ 443 $ 262
Professional fees 552 252
Selling expenses 508 395
Manufacturing costs 253 596
Other vendors 66 518
Total accounts payable 1,822 2,023
Accrued interest payable, related parties 79 41
Accrued interest payable 418 627
Accrued expenses:    
Payroll expenses 1,067 1,053
Government rebates and other rebates 2,553 2,659
Due to equity method investee 480 545
Other accrued expenses 554 512
Total accrued expenses 4,654 4,769
Total accounts payable and accrued expenses $ 6,973 $ 7,460